-
Mashup Score: 2
February 2025 FDA/ASCO Fellows’ Day Workshop The FDA/ASCO Fellows’ Day Workshop is designed to support trainees interested in drug development by providing an introduction to the U.S. Food and Drug Administration (FDA), clinical trial design, oncology drug regulatory science and the drug/device approval process. Oncology refers to solid tumors and hematologic malignancies throughout this document. *The February 20, 2025 workshop is a hybrid experience* Date & Time: Thursday, February 20, 2025 9:15 AM –
Source: asco.smapply.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4FDA approves updated drug labeling for fludarabine phosphate - 3 day(s) ago
On November 19, 2024, the FDA approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection, Sandoz) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at updating labeling information for certain older oncology drugs.
Source: www.fda.govCategories: General Medicine News, Hem/OncsTweet-
RT @FDAOncology: FDA approves updated drug labeling for fludarabine phosphate under Project Renewal. https://t.co/hDxJ0DLBMK #OCENewsBurst
-
-
Mashup Score: 4FDA approves updated drug labeling for fludarabine phosphate - 3 day(s) ago
On November 19, 2024, the FDA approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection, Sandoz) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at updating labeling information for certain older oncology drugs.
Source: www.fda.govCategories: General Medicine News, Hem/OncsTweet-
RT @FDAOncology: FDA approves updated drug labeling for fludarabine phosphate under Project Renewal. https://t.co/hDxJ0DLBMK #OCENewsBurst
-
-
Mashup Score: 10
To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of menopause.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet-
RT @drteplinsky: https://t.co/ZL3er5vikV More reassuring data on safety of vaginal estrogen - meta analysis shows no increase in risk of #…
-
-
Mashup Score: 10
To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of menopause.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet-
RT @drteplinsky: https://t.co/ZL3er5vikV More reassuring data on safety of vaginal estrogen - meta analysis shows no increase in risk of #…
-
-
Mashup Score: 2
Jeffrey Davis reviews some of the major themes in the annual Medicare FFS regs in both the Trump and Biden Administrations
Source: www.mcdermottplus.comCategories: General Medicine News, Hem/OncsTweet-
RT @JeffreyLDavis44: HAPPY HALLOWEEN!🎃 This week’s Regs & “Deviled” Eggs is out!! https://t.co/omWljsH0Nc My colleague Leigh Feldma…
-
-
Mashup Score: 0Melanoma Matters - 1 month(s) ago
Podcast · Melanoma Matters Pod · From the UK to the USA – Melanoma Matters is on a mission! Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices…across the pond(s). #MelanomaMatters
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet-
The link for @Spotify: https://t.co/H1SQMcywHr
-
-
Mashup Score: 2
Oncoinfluencers to Follow on Social Media: Dr. Shikha Jain / cancer, health care, LinkedIn, OncoDaily, OncoInfluencers, Oncoinfluencers to Follow on Social
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Oncoinfluencers to Follow on Social Media: Dr. @ShikhaJainMD https://t.co/L9ve1lEo6f #Cancer #HealthCare #OncoDaily #Onco…
-
-
Mashup Score: 2Rena Jones Awarded Scientific Tenure by the NIH - 2 month(s) ago
Dr. Rena Jones was awarded scientific tenure by the NIH and promoted to senior investigator in the Occupational and Environmental Epidemiology Branch in October 2024. She studies the effects of environmental exposures on cancer risk.
Source: dceg.cancer.govCategories: General Medicine News, Hem/OncsTweet-
RT @epi_rena: 🎉🎉 https://t.co/AWXik9Dd9O
-
-
Mashup Score: 1Successful Treatment of HIV-associated Kaposi’s Sarcoma with Immune Checkpoint Blockade - 2 month(s) ago
Kaposi’s sarcoma (KS) is an incurable, HIV-associated malignancy. We reviewed 320 immunotherapy-treated patient records. Seventeen had HIV-associated malignancies, including nine men with KS. Median viral load was 20 copies/mL (range: undetectable …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
@AaronGoodman33 @NCItreatment @NCIResearchCtr @fredhutch @theNCI @JCO_ASCO @Dr_R_Kurzrock I know the paper, but prospective trials are still important! https://t.co/ndD2Yk450w
-
RT @FDAOncology: Apply by December 4 for the February 2025 Hybrid FDA-@ASCO Fellows’ Day Workshop! https://t.co/5QfZ5rWOb8 #MedEd #hemeonc…